Images List Premium Download Classic

Inflammation

Inflammation-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
The Regents Of The University Of California
September 14, 2017 - N°20170260236

Provided are compositions, including isolated, synthetic or recombinant peptides for: expanding regulatory t cells (treg) populations; for treating or ameliorating a vascular inflammation, and kawasaki disease (kd) or a pediatric acute vasculitis of the coronary arteries, including vascular coronary abnormalities, and acute or chronic vascular inflammatory abnormalities, and methods for making and using them. Provided are immunotherapies for promoting expansion ...
C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
The Regents Of The University Of California
September 14, 2017 - N°20170260227

Wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds, for example, as antioxidant inflammation modulators, and compositions thereof are also provided.
Heterocyclic itk inhibitors for treating inflammation and cancer
The Regents Of The University Of California
September 14, 2017 - N°20170260211

Wherein r1, r2, and x are as defined in the detailed description. Methods of inhibition of itk activity in a human or animal subject are also provided.
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Benzene, pyridine, and pyridazine derivatives
Vichem Chemie KutatÓ Kft.
September 14, 2017 - N°20170260174

Wherein r1, r2, r3, r4, r5, r6, r7, n, q1, q2, q3, y, and x1-x4 are as defined herein. Compounds of formula i are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of ...
Water soluble haloanilide calcium-release calcium channel inhibitory compounds and methods to control bone erosion and ...
West Virginia University
September 14, 2017 - N°20170260128

A compound that is selected from the group consisting of 3-(3,4-dichloroanilino)-3-oxopropanoic acid (hereinafter “dcopa”); n-methyl-dcopa; n,2-dimethyl-dcopa; 2-methyl-dcopa; isobutyl-dcopa; n-methyl-isobutyl dcopa; 3-(3,4-bibromoanilino)-3-oxopropanoic acid; and analogs of dcopa; and analogs of 3-(3,4-bibromoanilino)-3-oxopropanoic acid; and pharmaceutically acceptable salts of these compounds, are disclosed. A method of controlling bone erosion ...
Viral conjunctivitis treatment using ranpirnase and/or amphinase
Okogen, Inc
September 14, 2017 - N°20170258876

The present specification discloses ranpirnase and amphinase, compositions comprising ranpirnase and/or amphinase, and methods and uses to treat a viral conjunctivitis, an epidemic keratoconjunctivitis, and/or a pharyngoconjunctival fever, reduce or suppress a level of virus or viral titer, reduce or suppress viral replication, reduce or suppress protein synthesis, reduce or suppress a level of a trna, reduce or ...
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods, agents and compositions for treatment of inflammatory conditions
Betanien Hospital
September 14, 2017 - N°20170258867

The present invention relates to the screening, diagnosis, prognostic evaluation, and treatment or prevention of age associated inflammation, chronic inflammation, and inflammatory diseases. In particular, the present invention relates to treating or preventing inflammatory diseases (e. G. Rheumatoid arthritis or spondyloarthritis) or patients with inflammatory peripheral gnrh with gnrh antagonists or drugs that lower the effects of gnrh.
Metatarsal pain relief gel strip
Inwest Manufacturing Lp
September 14, 2017 - N°20170258625

A metatarsal pain relief gel strip can be used to treat and/or prevent morton's neuroma and possibly other forefoot conditions. The pain relief gel strip can include an arched or protruding gel structure that is secured within an adhesive material to allow the gel structure to be maintained on the underside of the foot between adjacent toes. Due to ...
Compositions and methods of selectively inhibiting irp1 and treating inflammation
Technion Research & Development Foundation Limited
September 07, 2017 - N°20170253881

Compositions and methods of treating an inflammatory disease in a subject are provided. Accordingly there is provided a method comprising administering to the subject a therapeutically effective amount of an agent which selectively inhibits activity and/or expression of iron regulatory protein (irp) 1 and not irp2, thereby treating the inflammatory disease in the subject. Also provided is a pharmaceutical composition ...
Methods for inhibiting fibrosis in a subject in need thereof
Omeros Corporation
September 07, 2017 - N°20170253667

In one aspect, the invention provides methods for treating, inhibiting, alleviating or preventing fibrosis in a mammalian subject suffering, or at risk of developing a disease or disorder caused or exacerbated by fibrosis and/or inflammation. In one embodiment, the invention provides methods of treating a subject suffering from renal fibrosis. In one embodiment, the invention provides methods of reducing ...
Anti-age antibodies for treating inflammation and auto-immune disorders
Siwa Corporation
August 31, 2017 - N°20170247472

A composition for treating inflammation or auto-immune disorders comprises (i) an antibody that binds to an age-modified protein on a cell, and (ii) an anti-inflammation antibody. Furthermore, the antibody that binds to an age-modified protein on a cell is also effective to treat inflammation or auto-immune disorders alone.
Modulation of ptpra to treat arthritis
The Regents Of The University Of California
August 31, 2017 - N°20170247469

Presented is a method for treating inflammation and autoimmune diseases through the use of a phosphatase rheumatoid arthritis (pt-pra) antagonist.
Pharmaceutical composition for treating infertility, and preparation method and use thereof
Sichuan Sainthood Biotech Co., Ltd.
August 31, 2017 - N°20170246230

The present invention provides a drug combination for the treatment of infertility and its crude drug comprises the medical ingredients with their weight proportions listed as below: 10-20 amounts by weight of rehmannia, 10-20 amounts by weight of chinese peony, 10-20 amounts by weight of asiatic dogwood, 10-20 amounts by weight of chinese yam, 10-20 amounts by weight of poria, 15...
Inflammation Patent Pack
Download 558+ patent application PDFs
Inflammation Patent Applications
Download 558+ Inflammation-related PDFs
For professional research & prior art discovery
inventor
  • 558+ full patent PDF documents of Inflammation-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Ex-vivo induced regulatory mesenchymal stem cells or myeloid-derived suppressor cells as immune modulators
Hadasit Medical Research Services & Development Ltd
August 31, 2017 - N°20170246210

A composition comprising tgfβ, an inflammatory agent and a tryptophan indoleamine-2,3 dioxygenase (ido) metabolite, in particular, tgfβ, ifnγ and kynurenine, is provided, as well as regulatory mesenchymal stem cell lines or myeloid-derived suppressor cell lines obtained by contacting mesenchymal stem cell lines or myeloid-derived suppressor cell lines, respectively, with the composition. Methods for inhibiting ...
Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
Omeros Corporation
August 31, 2017 - N°20170246150

A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline ...
Biomarkers for diagnosis and management of neuro-immunological diseases
Montana State University
August 24, 2017 - N°20170242043

Biomarkers associated with neuroimmunological disease are described. The disclosed biomarkers are secreted proteins identified in cerebral spinal fluid (csf) samples of patients with neurological disease. The disclosed biomarkers identify patients with intrathecal inflammation, distinguish multiple sclerosis (ms) patients from patients with other types of inflammatory neurological diseases and from subjects without ms, distinguish progressive ms patients from patients with relapsing-remitting ...
Bioeffective krill oil compositions
Aker Biomarine Antarctic As
August 24, 2017 - N°20170240842

This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical co2 or co2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill ...
Anti-pd-1 monoclonal antibody and obtaining method therefor
Beijing Jingyitaixiang Technology Development Co., Ltd.
August 24, 2017 - N°20170240644

The invention provides human monoclonal antibodies that specifically bind to pd-1 with high affinity. The anti-pd-1 monoclonal antibodies were screened from a synthetic antibody library, and affinity maturation was performed. The synthetic antibody libraries used to select for the high affinity anti-pd-1 monoclonal antibodies were made by replacing the light chain cdr1, cdr2 and cdr3 and heavy chain cdr1, cdr 2 ...
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders
Beijing Jingyitaixiang Technology Development Co., Ltd.
August 24, 2017 - N°20170240556

A is a bond, alkyl or alkoxy optionally substituted with one or more r″ as defined herein, *—n(r′″)co—, *—con(r′″)—, *—n(r′″)con(r′″)—, —s—, —so—, *—n(r′″)—, *—n(r′″)co—, *&#...
Soluble epoxide hydrolase inhibitors and uses thereof
X-chem, Inc.
August 24, 2017 - N°20170240526

The present invention features compounds having soluble epoxide hydrolase inhibitory activity. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions, such as cardiovascular diseases, respiratory diseases, inflammation, and diabetes.
Reversible immobilization and/or controlled relase of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
Curevac Ag
August 24, 2017 - N°20170239372

The present invention relates to nanoparticles comprising nucleic acids coated with a (biodegradable) polymer for reversible immobilization and/or controlled release of the nucleic acid comprising nanoparticles. Furthermore, the present invention is directed to medical or diagnostic devices, particularly stents and implants coated by a (biodegradable) polymer with the nucleic acid comprising nanoparticles for reversible immobilization and/or controlled release. ...
Loading